Mark Roithmayr leads the Alzheimer's Drug Discovery Foundation (ADDF). See sector focus and contact routes.
Mark Roithmayr leads the Alzheimer's Drug Discovery Foundation (ADDF), an organization dedicated to accelerating drug discovery for Alzheimer's disease and related dementias. Under his leadership, the ADDF employs a venture philanthropy model, strategically investing in promising research initiatives globally. These investments are structured with terms comparable to those of traditional venture capital firms, ensuring a professional and impactful approach to funding. All financial returns generated from these investments are reinvested directly into the ADDF's charitable mission, further supporting the development of therapeutics for conditions like Frontotemporal Degeneration (FTD) and other neurodegenerative diseases. This unique model allows the ADDF to drive innovation in the field, focusing on the most impactful scientific advancements worldwide.
Details on this investor come from filing and round data held in the StartupFundraising directory, refreshed on ingest. Founders use profiles like this one to qualify fit and to shortlist investors in New York.
Investors like Mark Roithmayr · Full investor directory · Investor access · Company funding database